In a significant advance for multiple sclerosis (MS) research, a new study has uncovered a potential link between certain initial symptoms and long-term disability outcomes.

Multiple sclerosis (MS) research has uncovered a potential link between certain initial symptoms and long-term disability ...

Systemic sclerosis is an autoimmune disease that primarily causes inflammation of the skin, as well as internal organs such ...

The revisions signal a shift toward looking at MS more as a biologically based disease, noted Xavier Montalban, MD, PhD, of ...

[10] Conti P, Kempuraj D. Important role of mast cells in multiple sclerosis. Mult Scler Relat Disord. 2016;5:77-80. [11] Skaper SD, Facci L, Giusti P. Mast cells, glia and neuroinflammation: partners ...

Columnist Desiree Lama has accepted her MS diagnosis as part of her identity — but it's not the only thing that defines her, ...

Highly effective MS treatments like monoclonal antibodies and immune-suppressing drugs “may lead to better clinical outcomes ...

“If not treated early upon diagnosis, multiple sclerosis can lead to significant ... senior vice president and head of clinical development, Immunology, Cardiovascular and Neuroscience, Bristol Myers ...

This Review discusses targeting cytokines and their receptors in non-infectious central nervous system inflammatory diseases such as multiple sclerosis and neurosarcoidosis, as well as in the ...

Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve fibres, leading to neurological disturbances. The mechanisms ...

Although facial angiofibromas are a strong indication of tuberous sclerosis complex when found with other manifestations, these lesions also occur in individuals with multiple endocrine neoplasia ...

Zenas BioPharma, which is developing immunology-based therapies, said on Friday it is targeting a valuation of as much as ...